Hunan Warrant Pharmaceutical (688799.SH) obtains the registration certificate for ibuprofen and adrenaline injection.

Recently, Hunan Warrant Pharmaceutical (688799.SH) announced that the company has received the Drug Registration Certificate for Carboprost Tromethamine Injection approved and issued by the State Food and Drug Administration. Carboprost Tromethamine Injection is mainly used for the treatment of postpartum hemorrhage caused by uterine relaxation and dysfunction during the gestation period of 13 to 20 weeks when conventional treatment methods are ineffective. The company's Carboprost Tromethamine Injection has obtained the Drug Registration Certificate for chemical drugs under a new registration classification system, which is considered equivalent to passing consistency evaluation.